{
    "organizations": [],
    "uuid": "e92548c9019452a3345334d576b7cef809146ce4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cadila-healthcare-says-zydus-recei/brief-cadila-healthcare-says-zydus-received-final-approval-from-usfda-for-bumetanide-tablets-usp-idUSFWN1S90XK",
    "ord_in_thread": 0,
    "title": "BRIEF-Cadila Healthcare Says Zydus Received Final Approval From USFDA For Bumetanide Tablets USP",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Cadila Healthcare Ltd:\n* SAYS ZYDUS RECEIVED FINAL APPROVAL FROM USFDA FOR BUMETANIDE TABLETS USP Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T20:35:00.000+03:00",
    "crawled": "2018-05-03T12:05:41.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cadila",
        "healthcare",
        "ltd",
        "say",
        "zydus",
        "received",
        "final",
        "approval",
        "usfda",
        "bumetanide",
        "tablet",
        "usp",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}